Related Experiment Video
Updated: May 1, 2026

Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
The nickel dose-response relationship by filaggrin genotype (FLG)
Katrine Ross-Hansen1, Jeanne D Johansen, Aage Vølund
1Department of Dermato-Allergology, National Allergy Research Centre, Copenhagen University Hospital Gentofte, Hellerup, 2900, Denmark.
Filaggrin gene (FLG) null mutations do not appear to affect the nickel elicitation threshold in individuals sensitized to nickel. This suggests FLG carrier status is not a determining factor in nickel sensitivity reactions.
Area of Science:
- Dermatology
- Genetics
- Toxicology
Background:
- Nickel exposure can lead to skin accumulation, potentially binding to proteins like filaggrin.
- Filaggrin gene (FLG) null mutations impair filaggrin production and are linked to increased nickel sensitization risk.
- Filaggrin plays a role in skin barrier function and interaction with environmental allergens.
Purpose of the Study:
- To determine if heterozygous FLG mutation carriers have a different nickel elicitation threshold compared to non-carriers.
- Investigate the influence of FLG genotype on the dose-response relationship for nickel sensitization.
Main Methods:
- Patch testing and repeated open application tests (ROAT) were conducted on nickel-sensitized patients.
- Patients were genotyped for specific FLG mutations (R501X, 2282del4, R2447X).
- Logistic threshold dose-response analyses compared mutation carriers and non-carriers.
Main Results:
- No significant difference was observed in the dose-response relationship between FLG mutation carriers and non-mutation carriers.
- The study found no variation in how nickel elicited reactions based on FLG single-allele carrier status.
Conclusions:
- Nickel elicitation threshold appears independent of FLG null mutation single-allele carrier status in this cohort.
- Findings suggest that FLG genotype may not be a primary determinant for the severity of nickel sensitization reactions.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

